1
|
Bellissima A, Cucci LM, Sanfilippo V, De Bonis A, Fiorenza R, Scirè S, Marzo T, Severi M, La Mendola D, Notarstefano V, Giorgini E, Satriano C. Pd-Based Hybrid Nanoparticles As Multimodal Theranostic Nanomedicine. ACS APPLIED BIO MATERIALS 2023; 6:483-493. [PMID: 36651801 PMCID: PMC9945085 DOI: 10.1021/acsabm.2c00759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
A nanodelivery system based on palladium nanoparticles (PdNP) and cisplatin (CisPt) was developed by physisorption of the drug onto the PdNP synthesized via a green redox process, using d-glucose and polyvinylpyrrolidone (PVP) as reducing and stabilizing/capping agents, respectively. UV-vis analysis and H2-evolution measurements were carried out to prove the nanoparticles' capability to act as bimodal theranostic nanomedicine, i.e., having both plasmonic and photocatalytic properties. XPS, XRD, and TEM allowed light to be shed on the chemical composition and morphology of the PdNP. The analysis of the UV-visible spectra evidenced plasmonic peak changes for the hybrid nanoparticle-drug assembly (Pd@CisPt), which pointed to a significant interaction of CisPt with the NP surface. The drug loading was quantitatively estimated by ICP-OES measurements, while DLS and AFM confirmed the strong association of the drug with the nanoparticle surface. The test of SOD-like activity in a cell-free environment proved the maintenance of the antioxidant capability of PdNP also in the Pd@CisPt systems. Finally, Pd@CisPt tested in prostate cancer cells (PC-3 line) unveiled the antitumoral action of the developed nanomedicine, related to reactive oxygen species (ROS) generation, with a condition of protein misfolding/unfolding and DNA damage, as evidenced by cytotoxicity and MitoSOX assays, as well as Raman microspectroscopy, respectively. Cell imaging by confocal microscopy evidenced cellular uptake of the nanoparticles, as well as dynamic processes of copper ion accumulation at the level of subcellular compartments. Finally, cell migration studies upon treatment with Pd@CisPt evidenced a tunable response between the inhibitory effect of CisPt and the enhanced rate of cell migration for the metal NP alone, which pointed out the promising potential of the developed theranostic nanomedicine in tissue regeneration.
Collapse
Affiliation(s)
- Alberto Bellissima
- Nano
Hybrid BioInterfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125Catania, Italy
| | - Lorena M. Cucci
- Nano
Hybrid BioInterfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125Catania, Italy
| | - Vanessa Sanfilippo
- Nano
Hybrid BioInterfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125Catania, Italy
| | - Angela De Bonis
- Department
of Science, University of Basilicata, viale dell’Ateneo Lucano,
10, 85100Potenza, Italy
| | - Roberto Fiorenza
- Department
of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125Catania, Italy
| | - Salvatore Scirè
- Department
of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125Catania, Italy
| | - Tiziano Marzo
- Department
of Pharmacy, University of Pisa, via Bonanno Pisano 6, 56126Pisa, Italy
| | - Mirko Severi
- Department
of Chemistry ‘‘U. Schiff’’, University of Florence, via della Lastruccia 3, 50019Sesto Fiorentino, Italy
| | - Diego La Mendola
- Department
of Pharmacy, University of Pisa, via Bonanno Pisano 6, 56126Pisa, Italy
| | - Valentina Notarstefano
- Department
of Life and Environmental Sciences, Polytechnic
University of Marche, Via Brecce Bianche, 60131Ancona, Italy
| | - Elisabetta Giorgini
- Department
of Life and Environmental Sciences, Polytechnic
University of Marche, Via Brecce Bianche, 60131Ancona, Italy
| | - Cristina Satriano
- Nano
Hybrid BioInterfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125Catania, Italy,Phone: +39 095 7385136. E-mail:
| |
Collapse
|
2
|
Wang Y, Zhang Y, Zhang X, Zhang Z, She J, Wu D, Gao W. High Drug-Loading Nanomedicines for Tumor Chemo-Photo Combination Therapy: Advances and Perspectives. Pharmaceutics 2022; 14:pharmaceutics14081735. [PMID: 36015361 PMCID: PMC9415722 DOI: 10.3390/pharmaceutics14081735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Revised: 08/14/2022] [Accepted: 08/16/2022] [Indexed: 11/28/2022] Open
Abstract
The combination of phototherapy and chemotherapy (chemo−photo combination therapy) is an excellent attempt for tumor treatment. The key requirement of this technology is the high drug-loading nanomedicines, which can load either chemotherapy drugs or phototherapy agents at the same nanomedicines and simultaneously deliver them to tumors, and play a multimode therapeutic role for tumor treatment. These nanomedicines have high drug-loading efficiency (>30%) and good tumor combination therapeutic effect with important clinical application potential. Although there are many reports of high drug-loading nanomedicines for tumor therapy at present, systematic analyses on those nanomedicines remain lacking and a comprehensive review is urgently needed. In this review, we systematically analyze the current status of developed high drug-loading nanomedicines for tumor chemo−photo combination therapy and summarize their types, methods, drug-loading properties, in vitro and in vivo applications. The shortcomings of the existing high drug-loading nanomedicines for tumor chemo−photo combination therapy and the possible prospective development direction are also discussed. We hope to attract more attention for researchers in different academic fields, provide new insights into the research of tumor therapy and drug delivery system and develop these nanomedicines as the useful tool for tumor chemo−photo combination therapy in the future.
Collapse
Affiliation(s)
- Ya Wang
- Center for Gut Microbiome Research, Med-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, China
| | - Yujie Zhang
- Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, China
| | - Xiaojiang Zhang
- Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, China
| | - Zhe Zhang
- Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, China
| | - Junjun She
- Center for Gut Microbiome Research, Med-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, China
- Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, China
- Correspondence: (J.S.); (D.W.); (W.G.)
| | - Daocheng Wu
- Key Laboratory of Biomedical Information Engineering of the Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China
- Correspondence: (J.S.); (D.W.); (W.G.)
| | - Wei Gao
- Department of Anesthesiology & Center for Brain Science & Center for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
- Correspondence: (J.S.); (D.W.); (W.G.)
| |
Collapse
|
3
|
Wu J, Wang M, Pan Y, Pang Y, Tang Y, Song C, Zhu J, Zhang X, Huang Q. Synthesis of manganese-oxide and palladium nanoparticles co-decorated polypyrrole/graphene oxide (MnO 2@Pd@PPy/GO) nanocomposites for anti-cancer treatment. RSC Adv 2022; 12:23786-23795. [PMID: 36093248 PMCID: PMC9394591 DOI: 10.1039/d2ra03860a] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 08/15/2022] [Indexed: 12/02/2022] Open
Abstract
Design and fabrication of novel multifunctional nanomaterials as novel “theranostic nanoagents”with high efficiency and low side effects is important for cancer treatment. Herein, we synthesized manganese-oxide and palladium nanoparticle-co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanocomposites, which could be used as a novel “theranostic nanoagent” for cancer treatment. Various spectroscopic and microscopic characterizations of the synthesized MnO2@Pd@PPy/GO nanocomposites suggest that the nanocomposites are assembled sequentially by graphene oxide, polypyrrole, palladium nanoparticles and manganese-oxide nanoplates. Further research revealed that the nanocomposites had excellent photothermal conversion performance (reached near 50 °C after 10 min of irradiation), pH responsive enzymatic-like catalytic activity and enhanced magnetic resonance imaging (MRI) performance (r1 = 7.74 mM−1 s−1 at pH 5.0 and glutathione (GSH)). Cell experiments also testified that combined cancer treatment (the viability of cancer cells is 30%) with photothermal therapy (PTT, the viability of cancer cells is 91% only with irradiation) and chemodynamic therapy (CDT, the viability of cancer cells is 74.7% only with nanocomposites) guided by MRI was achieved when the as-prepared nanocomposites were employed as theranostic nanoagents. This work could provide some new ideas for the controllable synthesis and application of multicomponent nanomaterials. Manganese-oxide and palladium nanoparticle-co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanoenzyme composites were synthesized, and could be as a novel “theranostic nanoagent” for cancer treatment due to excellent performance.![]()
Collapse
Affiliation(s)
- Jiarui Wu
- Public Experimental Research Center, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
- The First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Meng Wang
- Public Experimental Research Center, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
| | - Yuanjie Pan
- School of Pharmacy, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
| | - Yipeng Pang
- School of Life Science, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
| | - Yanyan Tang
- The First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Chang Song
- School of Pharmacy, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
| | - Jiahui Zhu
- School of Life Science, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
| | - Xian Zhang
- The First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
| | - Qingli Huang
- Public Experimental Research Center, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
- School of Pharmacy, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
| |
Collapse
|
4
|
Haque S, Tripathy S, Patra CR. Manganese-based advanced nanoparticles for biomedical applications: future opportunity and challenges. NANOSCALE 2021; 13:16405-16426. [PMID: 34586121 DOI: 10.1039/d1nr04964j] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Nanotechnology is the most promising technology to evolve in the last decade. Recent research has shown that transition metal nanoparticles especially manganese (Mn)-based nanoparticles have great potential for various biomedical applications due to their unique fundamental properties. Therefore, globally, scientists are concentrating on the development of various new manganese-based nanoparticles (size and shape dependent) due to their indispensable utilities. Although numerous reports are available regarding the use of manganese nanoparticles, there is no comprehensive review highlighting the recent development of manganese-based nanomaterials and their potential applications in the area of biomedical sciences. The present review article provides an overall survey on the recent advancement of manganese nanomaterials in biomedical nanotechnology and other fields. Further, the future perspectives and challenges are also discussed to explore the wider application of manganese nanoparticles in the near future. Overall, this review presents a fundamental understanding and the role of manganese in various fields, which will attract a wider spectrum of the scientific community.
Collapse
Affiliation(s)
- Shagufta Haque
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad - 500007, Telangana State, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, U.P., India
| | - Sanchita Tripathy
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad - 500007, Telangana State, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, U.P., India
| | - Chitta Ranjan Patra
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad - 500007, Telangana State, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, U.P., India
| |
Collapse
|
5
|
Jain P, Patel K, Jangid AK, Guleria A, Patel S, Pooja D, Kulhari H. Modulating the Delivery of 5-Fluorouracil to Human Colon Cancer Cells Using Multifunctional Arginine-Coated Manganese Oxide Nanocuboids with MRI Properties. ACS APPLIED BIO MATERIALS 2020; 3:6852-6864. [PMID: 35019347 DOI: 10.1021/acsabm.0c00780] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
5-Fluorouracil (5-FU) is one of the most prescribed drugs and the major component of chemotherapy for the treatment of colorectal cancer. In this study, we have designed arginine-functionalized manganese oxide nanocuboids (Arg@MNCs) for the effective delivery of 5-FU to colon cancer cells. Arginine was used as multifunctional agent to provide stability to MNCs, achieve high drug loading, control the release of loaded drug, and improve delivery to cancer cells. The synthesized Arg@MNCs were characterized by DLS, TEM, XRD, FTIR, XPS, TGA, and VSM analysis. The structural and morphological analysis by TEM showed cuboid-shaped MNCs with average particle size ∼15 nm. Biodegradation studies indicated that the Arg@MNCs were degraded at endolyosomal pH in 24 h while remaining stable at physiological pH. Hemolytic toxicity studies revealed the safety and nontoxic nature of the prepared MNCs. 5-FU-loaded Arg@MNCs showed significant control over the release of 5-FU, decrease in the hemolytic toxicity of loaded 5-FU but higher in vitro anticancer activity against HCT 116 and SW480 human colon cancer cells. Importantly, both the bare MNCs and Arg@MNCs showed excellent T1 and T2MR relaxivity under 3.0 T MRI scanner. Thus, the nanostructures developed in this study, i.e., 5-FU-Arg@MNCs could overcome the issues of both MNCs (stability) and 5-FU (low drug loading and nonspecificity) and may be used as a multifunctional theranostic nanocarrier for colon cancer treatment.
Collapse
Affiliation(s)
| | | | | | - Anupam Guleria
- Centre of Biomedical Research, SGPGIMS Campus, Lucknow 226014, India
| | | | - Deep Pooja
- The Centre for Advanced Materials & Industrial Chemistry, Applied Sciences, RMIT University, 124 La Trobe Street, Melbourne 3000, Australia
| | | |
Collapse
|
6
|
Abstract
Recent achievements of MnO2-based nanosystems for various cancer therapies are comprehensively reviewed.
Collapse
Affiliation(s)
- Jia Wen
- Key Laboratory of Pharmaceutical Quality Control of Hebei Province
- College of Pharmaceutical Science
- Hebei University
- Baoding 071002
- China
| | - Kui Yang
- Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education
- Key Laboratory of Chemical Biology of Hebei Province
- College of Chemistry and Environmental Science
- Hebei University
- Baoding 071002
| | - Shiguo Sun
- Key Laboratory of Xinjiang Phytomedicine Resource and Utilization
- Ministry of Education
- School of Pharmacy
- Shihezi University
- Shihezi 832002
| |
Collapse
|